Collegium Pharmaceutical
COLL
eBay
EBAY
Halozyme Therapeutics
HALO
SilverCrest Metals
SILV
Workday
WDAY
US Stock MarketDetailed Quotes
OST Ostin Technology Group
- 2.430
- +0.010+0.41%
Close Jan 8 16:00 ET
- 2.250
- -0.180-7.41%
Post 17:29 ET
4.40MMarket Cap-0.34P/E (TTM)
2.740High2.040Low4.78MVolume2.440Open2.420Pre Close11.49MTurnover459.39%Turnover RatioLossP/E (Static)1.81MShares7.80052wk High0.43P/B2.53MFloat Cap1.60052wk Low--Dividend TTM1.04MShs Float477.900Historical High--Div YieldTTM28.93%Amplitude1.600Historical Low2.402Avg Price1Lot Size
Ostin Technology Group News
Ostin Technology Group | 6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment)
Ostin Technology Group | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ostin Technology Group | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ostin Technology Group | 424B5: Prospectus
Ostin Technology Group | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ostin Technology Group | 144: Notice of proposed sale of securities pursuant to Rule 144
Ostin Technology Group | 144: Notice of proposed sale of securities pursuant to Rule 144
Ostin Technology Group | 6-K: Report of foreign private issuer (related to financial reporting)
Ostin Technology Group | EFFECT: Others
Ostin Technology Group | CORRESP: CORRESP
Ostin Technology Group | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)
Ostin Technology Group | 6-K: Report of foreign private issuer (related to financial reporting)
Ostin Technology Group | 6-K: Report of foreign private issuer (related to financial reporting)
Ostin Technology Group | UPLOAD: Others
Ostin Technology Group | F-1: Registration statement for securities of certain foreign private issuers
Ostin Technology Group | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Ostin Technology Group | 424B5: Prospectus
Ostin Technology Group | EFFECT: Others
Ostin Technology Group | CORRESP: CORRESP
Ostin Technology Group | 144: Notice of proposed sale of securities pursuant to Rule 144